Skip to main content

1 results

IBD Treatment News: Changes to Xeljanz Boxed Warning & New Humira Biosimilar Approved

July 31, 2019

In July, the U.S. Food & Drug Administration (FDA) made two announcements regarding IBD treatments: New HUMIRA® biosimilar approved for ulcerative colitis and adult Crohn’s disease patients The FDA announced the approval of HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMI...

Read more...
Sections
Clinical Trials Community (1)
Topics
(X) Biologics (1)

Browser not supported

Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options:

Google Chrome

Download Chrome

Firefox

Download Firefox

Safari (macOS 10.8+ only)

Download Safari